Investing in a global pooled-funding mechanism for late-stage clinical trials of poverty-related and neglected diseases: an economic evaluation

INTRODUCTION: Poverty-related and neglected diseases (PRNDs) cause over three million deaths annually. Despite this burden, there is a large gap between actual funding for PRND research and development (R&D) and the funding needed to launch PRND products from the R&D pipeline. This study pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmerman, Armand, Diab, Mohamed Mustafa, Schäferhoff, Marco, McDade, Kaci Kennedy, Yamey, Gavin, Ogbuoji, Osondu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230859/
https://www.ncbi.nlm.nih.gov/pubmed/37247874
http://dx.doi.org/10.1136/bmjgh-2023-011842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230859/
https://www.ncbi.nlm.nih.gov/pubmed/37247874
http://dx.doi.org/10.1136/bmjgh-2023-011842

Ejemplares similares